Molecular Devices Inc.

SUNNYVALE, California, July 12, 2011 - Molecular Devices Inc., a leader in bioanalytical systems for drug discovery & development, life science research, and bioassay/test development, today announced that it has expanded the functionality of the SoftMax Pro Software and prominence of the SpectraMax microplate readers, enabling monitor and control ability via an Apple iPad wireless device.

SUNNYVALE, California, July 5, 2011 - Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced that the Drug Discovery Division of Genetix will join Molecular Devices.

SUNNYVALE, California, May 17, 2011 - Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced that NanoRacks, LLC has chosen the SpectraMax(R) M5e Multi-Mode Microplate Reader for use in NASA's International Space Station; the M5e Reader will be the first microplate reader to be used in space.

SUNNYVALE, California, May 12, 2011 - De Novo Software(TM), a leading provider of flow and image cytometry data analysis solutions, and Molecular Devices, a provider of premier bioresearch and drug discovery systems, announced today a licensing agreement enabling Molecular Devices to distribute De Novo Software's flagship product, FCS Express 4 Software.

SUNNYVALE, California, April 6, 2011 - Molecular Devices Inc., a leader in bioanalytical systems for drug discovery and development, life science research, and bioassay/test development, today announces the launch of its comprehensive online Knowledge Base mdc.custhelp.com.